Bariatric surgery increases risk of low blood sugar in obese diabetics: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-01-03 14:53 GMT | Update On 2021-01-04 01:04 GMT

UK: Obese patients with diabetes undergoing gastric bypass surgery are at increased risk of developing low blood sugar (hypoglycemia) post-surgery, suggests a recent study in the journal Diabetes Care. Postbariatric hypoglycemia could be due to a combination of increased glycemic variability (GV), increased GLP-1 response, and reduced levels of mean glucose.

Roux-en-Y gastric bypass (RYGB) is an established treatment for obesity and type 2 diabetes. Ibiyemi Ilesanmi, Imperial College London, London, U.K, and colleagues aimed to establish the effect of RYGB on GV and hypoglycemia in this prospective observational study of 10 patients with prediabetes or type 2 diabetes and obesity.

The patients were studied before RYGB and 1 month, 1 year, and 2 years postsurgery with continuous glucose measurement (CGM). A mixed-meal test (MMT) was conducted at Pre, 1 month, and 1 year.

Also Read: Roux-en-Y gastric bypass better than sleeve gastrectomy for weight loss: JAMA

Key findings of the study include:

After RYGB, mean CGM decreased (at 1 month, 1 year, and 2 years), and GV increased (at 1 year and 2 years).
Five of the 10 participants had a percent time in range (%TIR) <3.0 mmol/L (54 mg/dL) greater than the international consensus target of 1% at 1 or 2 years.
Peak glucagon-like peptide-1 (GLP-1) and glucagon area under the curve during MMT were positively and negatively associated, respectively, with contemporaneous %TIR <3.0 mmol/L.

"Our findings demonstrate that patients undergoing RYGB are at risk for development of postbariatric hypoglycemia due to a combination of reduced mean glucose level, increased GV, and increased GLP-1 response," concluded the authors.

Also Read: CGM improves blood sugar control, prevents hypoglycemia in T1D: Study

"Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study, is published in the journal Diabetes Care.

DOI: https://care.diabetesjournals.org/content/early/2020/12/14/dc20-1609

Article Source : Diabetes Care

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bariatric surgery increases risk of low blood sugar in obese diabetics: Study

Similar News

Higher Semaglutide Doses Safely Boost Weight Loss and Health in Adults with Obesity, Confirm Two Clinical Trials

Study Links Metabolic Syndrome to Adverse Coronary Plaque Profiles in T2DM

Diabetes Increases Risk of Oral and Maxillofacial Diseases: Study

Multifactorial Risk Control Lowers Liver Disease Burden in Type 2 Diabetes, Study Shows

Low Hb Levels may Increase Risk of Diabetic Retinopathy in Adults with Type 2 Diabetes: Study

New bioactive dressing promises faster diabetic wound healing, reveals research

Insulin degludec 3-times weekly Less Effective Than insulin glargine once-daily in Short-Term Glycemic Control: Study

Psoriatic Arthritis Patients Face Higher Burden of Metabolic Syndrome, Meta-Analysis Shows